129 related articles for article (PubMed ID: 18182806)
1. The MPO Study: just a European HEMO Study or something very different?
Locatelli F; Gauly A; Czekalski S; Hannedouche T; Jacobson SH; Loureiro A; Martin-Malo A; Papadimitriou M; Passlick-Deetjen J; Ronco C; Vanholder R; Wizemann V;
Blood Purif; 2008; 26(1):100-4. PubMed ID: 18182806
[TBL] [Abstract][Full Text] [Related]
2. Reduction in beta2-microglobulin with super-flux versus high-flux dialysis membranes: results of a 6-week, randomized, double-blind, crossover trial.
Pellicano R; Polkinghorne KR; Kerr PG
Am J Kidney Dis; 2008 Jul; 52(1):93-101. PubMed ID: 18423807
[TBL] [Abstract][Full Text] [Related]
3. The effect of on-line high-flux hemofiltration versus low-flux hemodialysis on mortality in chronic kidney failure: a small randomized controlled trial.
Santoro A; Mancini E; Bolzani R; Boggi R; Cagnoli L; Francioso A; Fusaroli M; Piazza V; Rapanà R; Strippoli GF
Am J Kidney Dis; 2008 Sep; 52(3):507-18. PubMed ID: 18617304
[TBL] [Abstract][Full Text] [Related]
4. [Clinical dialysis: new problems and new prospects].
Locatelli F; Manzoni C; Pozzoni P; Pontoriero G; Di Filippo L
G Ital Nefrol; 2004; 21(2):156-64. PubMed ID: 15351950
[TBL] [Abstract][Full Text] [Related]
5. Can convective therapies improve dialysis outcomes?
Locatelli F; Manzoni C; Cavalli A; Di Filippo S
Curr Opin Nephrol Hypertens; 2009 Nov; 18(6):476-80. PubMed ID: 19726986
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of dialysis outcomes: experimental versus observational evidence.
Locatelli F; Andrulli S; D'Amico M
J Nephrol; 2001; 14 Suppl 4():S101-8. PubMed ID: 11798140
[TBL] [Abstract][Full Text] [Related]
7. The effect of membrane permeability on ESRD: design of a prospective randomised multicentre trial.
Locatelli F; Hannedouche T; Jacobson S; La Greca G; Loureiro A; Martin-Malo A; Papadimitriou M; Vanholder R
J Nephrol; 1999; 12(2):85-8. PubMed ID: 10378663
[TBL] [Abstract][Full Text] [Related]
8. [Controlled randomized clinical trials].
Jaillon P
Bull Acad Natl Med; 2007; 191(4-5):739-56; discussion 756-8. PubMed ID: 18225427
[TBL] [Abstract][Full Text] [Related]
9. [Do convective treatments significantly reduce morbidity and mortality?].
Manzoni C; Cavalli A; Pontoriero G; Di Filippo S; Locatelli F
G Ital Nefrol; 2009; 26 Suppl 45():S16-9. PubMed ID: 19382089
[TBL] [Abstract][Full Text] [Related]
10. Resolving controversies regarding hemodiafiltration versus hemodialysis: the Dutch Convective Transport Study.
Penne EL; Blankestijn PJ; Bots ML; van den Dorpel MA; Grooteman MP; Nubé MJ; ter Wee PM;
Semin Dial; 2005; 18(1):47-51. PubMed ID: 15663765
[TBL] [Abstract][Full Text] [Related]
11. Biocompatibility and permeability of dialyzer membranes do not affect anemia, erythropoietin dosage or mortality in japanese patients on chronic non-reuse hemodialysis: a prospective cohort study from the J-DOPPS II study.
Yokoyama H; Kawaguchi T; Wada T; Takahashi Y; Higashi T; Yamazaki S; Fukuhara S; Akiba T; Akizawa T; Asano Y; Kurokawa K; Saito A;
Nephron Clin Pract; 2008; 109(2):c100-8. PubMed ID: 18596379
[TBL] [Abstract][Full Text] [Related]
12. Hemodiafiltration history, technology, and clinical results.
Ronco C; Cruz D
Adv Chronic Kidney Dis; 2007 Jul; 14(3):231-43. PubMed ID: 17603976
[TBL] [Abstract][Full Text] [Related]
13. Homocysteine as a risk factor for cardiovascular disease in patients treated by dialysis: a meta-analysis.
Heinz J; Kropf S; Luley C; Dierkes J
Am J Kidney Dis; 2009 Sep; 54(3):478-89. PubMed ID: 19359080
[TBL] [Abstract][Full Text] [Related]
14. Advantages of new hemodialysis membranes and equipment.
Vanholder R; Glorieux G; Van Biesen W
Nephron Clin Pract; 2010; 114(3):c165-72. PubMed ID: 19955821
[TBL] [Abstract][Full Text] [Related]
15. Mortality risk for dialysis patients with different levels of serum calcium, phosphorus, and PTH: the Dialysis Outcomes and Practice Patterns Study (DOPPS).
Tentori F; Blayney MJ; Albert JM; Gillespie BW; Kerr PG; Bommer J; Young EW; Akizawa T; Akiba T; Pisoni RL; Robinson BM; Port FK
Am J Kidney Dis; 2008 Sep; 52(3):519-30. PubMed ID: 18514987
[TBL] [Abstract][Full Text] [Related]
16. Short daily and nocturnal hemodialysis: new therapies for a new century?
Rocco MV
Saudi J Kidney Dis Transpl; 2009 Jan; 20(1):1-11. PubMed ID: 19112213
[TBL] [Abstract][Full Text] [Related]
17. Association between serum albumin and mortality in dialysis patients is partly explained by inflammation, and not by malnutrition.
de Mutsert R; Grootendorst DC; Indemans F; Boeschoten EW; Krediet RT; Dekker FW;
J Ren Nutr; 2009 Mar; 19(2):127-35. PubMed ID: 19218039
[TBL] [Abstract][Full Text] [Related]
18. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
Brandi L
Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
[TBL] [Abstract][Full Text] [Related]
19. Effect of membrane flux and dialyzer biocompatibility on survival in end-stage diabetic nephropathy.
Götz AK; Böger CA; Popal M; Banas B; Krämer BK
Nephron Clin Pract; 2008; 109(3):c154-60. PubMed ID: 18663328
[TBL] [Abstract][Full Text] [Related]
20. Comorbidity and acute clinical events as determinants of C-reactive protein variation in hemodialysis patients: implications for patient survival.
Snaedal S; Heimbürger O; Qureshi AR; Danielsson A; Wikström B; Fellström B; Fehrman-Ekholm I; Carrero JJ; Alvestrand A; Stenvinkel P; Bárány P
Am J Kidney Dis; 2009 Jun; 53(6):1024-33. PubMed ID: 19394732
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
